Clinical Trial Update: BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of BOLD-100 with doxorubicin in advanced soft tissue sarcoma; study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• BOLD-100
• Doxorubicin (doxorubicin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Sarcoma, Soft-tissue, Sarcoma | Phase 1 | Status: NOT_YET_RECRUITING